Drug combination reduces colon cancer risk (Reuters)

[feedbot]

Drug combination reduces colon cancer risk (Reuters)

Reuters - Combining a low dose of a targeted
cancer-fighter with an anti-inflammatory drug reduces the risk
of recurring colorectal polyps, an early sign of colon cancer,
by as much as 95 percent, researchers said on Monday.

http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cancer_colon_prevention_dc.html